Adrenal insufficiency induced by immune checkpoint inhibitors anticancer therapy

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and significantly improved the prognosisof patients with advanced tumors. The ICIs are monoclonal antibodies that inhibit regulatory proteins, namely cytotoxicT-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death 1...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Paulina Ramaneckaite, Zuzanna Ratuszna, Julia Brymora, Ewa Zalewska, Renata Stodulska-Świątkowska
Format:	Artigo
Jezik:	Inglês
Izdano:	Via Medica 2025-06-01
Serija:	Nowotwory
Teme:	adrenal cortex insufficiency immune-related adverse events anticancer drugs immune checkpoint inhibitors ACTH deficiency
Online dostop:	https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/104812
Oznake:	Označite Brez oznak, prvi označite!